search
Company Information
USD
1.75
- (-10.7%)
NASDAQ:SCLX, SCILEX HOLDING CO
Industry: Drug Manufacturers - General
End of Day: 21 June 2024 GMT-4
Scilex Holding Co is engaged in the development and commercialization of non-opioid pain management products. The company’s lead product ZTlido.

Address

960 San Antonio Road

Classification

Sector

Healthcare

Industry Group

Drug Manufacturers

Industry

Drug Manufacturers - General

Key Executives

Dr. Henry Ji,PhD
Chairman of the Board/Director
Dr. Yue Alexander Wu, PhD
Director
Mr. Stephen Ma
CFO/Chief Accounting Officer
Dr. Jay Chun, M.D.,PhD
Director
Mr. Jaisim Shah
CEO/Director/President
Mr. Dorman Followwill
Director
Mr. David Jakob Lemus
Director

Ownership

Institution Holdings

State Street Corporation
7,396,247 (4.620%)
BlackRock Inc
6,805,589 (4.251%)
SSGA Funds Management Inc
5,960,352 (3.723%)
Vanguard Group Inc
3,932,508 (2.457%)
Vanguard Investments Australia Ltd
2,574,482 (1.608%)
BlackRock Fund Advisors
2,317,776 (1.448%)
Sorrento Therapeutics Inc
1,917,210 (1.286%)
Fidelity Management & Research Company LLC
1,535,830 (0.959%)
Northern Trust Investments Inc
1,148,082 (0.717%)
Geode Capital Management, LLC
1,002,768 (0.626%)

Individual Holdings

Mr. Stephen Hoi Ma
467,861 (0.305%)
Dr. Jay Chun, M.D.,PhD
45,000 (0.029%)

Funds Holdings

BlackRock Extended Equity Market
298,880 (0.189%)
NT R2000 Index Fund - NL
200,796 (0.127%)
Cathay Genomics Immunology Revolutn ETF
187,364 (0.119%)
NT R2000 Index Fund - DC - NL
158,129 (0.100%)
NT Ext Equity Mkt Idx Fd - DC - NL
108,152 (0.068%)
BlackRock Russell 2500™ Index
102,794 (0.065%)
Fidelity Nasdaq Composite Index ETF
101,881 (0.065%)
Russell 2000 Index Non-Lendable Fund E
82,910 (0.053%)
Blackrock Russell 2000 Alpha Tilts
62,404 (0.040%)
BlackRock Russell 2000® Index NL
48,246 (0.031%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices